| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Streptococci (β-haemolytic + serogroup F) |
0.03 |
0.06 |
≤0.03 － 0.12 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.03 |
0.25 |
≤0.015 － 1 |
Ceftriaxone (Rocephin) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.06 |
0.12 |
0.008 － 0.25 |
Tigecycline (GAR-936, Tigacyl) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.06 |
0.12 |
0.03 － 1 |
Trovafloxacin (Trovan) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.06 |
0.25 |
≤0.06 － 0.25 |
Amoxicillin-clavulanic acid (Augmentin) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
>0.06 |
>4 |
≤0.03 － >4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.12 |
8 |
≤0.06 － >8 |
Minocycline (Minocycline hydrochloride, Minocin) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
≤0.25 |
≤0.25 |
≤0.25 － 0.5 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.25 |
0.5 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.25 |
0.5 |
0.12 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
>0.5 |
>8 |
0.12 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
462 |
| Streptococci (β-haemolytic + serogroup F) |
0.6 |
0.25 |
≤0.06 － 0.25 |
Ampicillin (Omnipen) |
462 |